Bruce Acres

2.7k total citations
49 papers, 1.9k citations indexed

About

Bruce Acres is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Bruce Acres has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 26 papers in Genetics and 20 papers in Molecular Biology. Recurrent topics in Bruce Acres's work include Immunotherapy and Immune Responses (31 papers), Virus-based gene therapy research (26 papers) and CAR-T cell therapy research (10 papers). Bruce Acres is often cited by papers focused on Immunotherapy and Immune Responses (31 papers), Virus-based gene therapy research (26 papers) and CAR-T cell therapy research (10 papers). Bruce Acres collaborates with scholars based in France, United States and Switzerland. Bruce Acres's co-authors include Jean‐Marc Limacher, Nadine Bizouarne, Patrick Squiban, Philippe Slos, Stéphane Paul, Éric Tartour, Jean‐Marc Balloul, Marie Paule Kiény, Miklos Pless and Jean‐Yves Bonnefoy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Bruce Acres

49 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Acres France	25	1.3k	819	738	536	248	49	1.9k
Judy Kantor United States	23	1.0k 0.8×	686 0.8×	488 0.7×	481 0.9×	239 1.0×	31	1.6k
Theresa J. Goletz United States	20	2.0k 1.6×	882 1.1×	897 1.2×	199 0.4×	382 1.5×	28	2.6k
S. V. S. Kashmiri United States	26	990 0.8×	808 1.0×	769 1.0×	207 0.4×	765 3.1×	60	2.1k
Shoshana Morecki Israel	24	1.0k 0.8×	909 1.1×	774 1.0×	955 1.8×	112 0.5×	72	2.4k
Hy Levitsky United States	7	2.2k 1.7×	949 1.2×	1.5k 2.0×	757 1.4×	174 0.7×	11	2.9k
Helen Sabzevari United States	27	2.3k 1.8×	689 0.8×	1.7k 2.3×	209 0.4×	159 0.6×	55	3.4k
Laurent Gauthier France	23	2.0k 1.5×	581 0.7×	806 1.1×	162 0.3×	518 2.1×	42	2.8k
Vivian B. Dissette United States	24	1.7k 1.4×	793 1.0×	1.1k 1.4×	489 0.9×	89 0.4×	29	2.3k
Stephen D. Lupton United States	15	1.2k 0.9×	774 0.9×	776 1.1×	673 1.3×	129 0.5×	19	2.3k
Holly M. Horton United States	20	668 0.5×	836 1.0×	591 0.8×	222 0.4×	658 2.7×	48	1.8k

Countries citing papers authored by Bruce Acres

Since Specialization

Citations

This map shows the geographic impact of Bruce Acres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Acres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Acres more than expected).

Fields of papers citing papers by Bruce Acres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Acres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Acres. The network helps show where Bruce Acres may publish in the future.

Co-authorship network of co-authors of Bruce Acres

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Acres. A scholar is included among the top collaborators of Bruce Acres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Acres. Bruce Acres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Acres, Bruce, G Lacoste, & Jean‐Marc Limacher. (2015). Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid Tumour. Current topics in microbiology and immunology. 405. 79–97. 10 indexed citations

Oudard, Stéphane, Olivier Rixe, Benoit Beuselinck, et al.. (2010). A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunology Immunotherapy. 60(2). 261–271. 71 indexed citations

Dummer, Reinhard, Stefan B. Eichmüller, Sylke Gellrich, et al.. (2010). Phase II Clinical Trial of Intratumoral Application of TG1042 (Adenovirus-interferon-γ) in Patients With Advanced Cutaneous T-cell Lymphomas and Multilesional Cutaneous B-cell Lymphomas. Molecular Therapy. 18(6). 1244–1247. 31 indexed citations

Dreicer, Robert, Walter M. Stadler, F. R. Ahmann, et al.. (2008). MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure. Investigational New Drugs. 27(4). 379–386. 58 indexed citations

Ramlau, Rodryg, Élisabeth Quoix, Janusz Rolski, et al.. (2008). A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(7). 735–744. 162 indexed citations

Dummer, Reinhard, Christoph Rochlitz, Thierry Velu, et al.. (2008). Intralesional Adenovirus-mediated Interleukin-2 Gene Transfer for Advanced Solid Cancers and Melanoma. Molecular Therapy. 16(5). 985–994. 39 indexed citations

Paul, Stéphane, Michel Geist, David Snary, et al.. (2007). Specific Tumor Cell Targeting by a Recombinant MVA Expressing a Functional Single Chain Antibody on the Surface of Intracellular Mature Virus (IMV) Particles. Viral Immunology. 20(4). 664–672. 4 indexed citations

Urosevic, Mirjana, Kazuyasu Fujii, Boris Calmels, et al.. (2007). Type I IFN innate immune response to adenovirus-mediated IFN-γ gene transfer contributes to the regression of cutaneous lymphomas. Journal of Clinical Investigation. 117(10). 2834–2846. 30 indexed citations

Paul, Stéphane, et al.. (2004). Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L. Cancer Gene Therapy. 12(2). 198–205. 57 indexed citations

10.

Rochlitz, Christoph, Robert A. Figlin, Patrick Squiban, et al.. (2003). Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer. The Journal of Gene Medicine. 5(8). 690–699. 139 indexed citations

11.

Rochlitz, Christoph, Brigitte Dréno, Peter Jantscheff, et al.. (2002). Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels. Cancer Gene Therapy. 9(3). 289–295. 27 indexed citations

12.

Paul, Stéphane, et al.. (2002). The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer. Cancer Immunology Immunotherapy. 51(11). 645–654. 12 indexed citations

13.

Acres, Bruce, et al.. (2001). Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth. Cancer Gene Therapy. 8(10). 815–826. 7 indexed citations

14.

Apostolopoulos, Vasso, et al.. (2000). Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice. Vaccine. 19(2-3). 158–162. 27 indexed citations

15.

Acres, Bruce, Vasso Apostolopoulos, Jean‐Marc Balloul, et al.. (2000). MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines. Cancer Immunology Immunotherapy. 48(10). 588–594. 87 indexed citations

16.

McKenzie, Ian F. C., Vasso Apostolopoulos, Pei‐Xiang Xing, et al.. (1998). Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses. Veterinary Immunology and Immunopathology. 63(1-2). 185–190. 22 indexed citations

17.

Maruyama, Haruhiko, Weiping Li, Jan Žaloudík, et al.. (1996). Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. International Journal of Cancer. 65(4). 547–553. 16 indexed citations

18.

Cao, Xuetao, et al.. (1996). Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus. Journal of Cancer Research and Clinical Oncology. 122(12). 716–722. 7 indexed citations

19.

Taupin, Jean‐Luc, Bruce Acres, Karin Dott, et al.. (1993). Immunogenicity of HILDA/LIF either in a Soluble or in a Membrane Anchored Form expressed In Vivo by Recombinant Vaccinia Viruses. Scandinavian Journal of Immunology. 38(3). 293–301. 17 indexed citations

20.

Morrissey, Philip, Raymond G. Goodwin, Richard P. Nordan, et al.. (1989). Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells.. The Journal of Experimental Medicine. 169(3). 707–716. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact